Colchicine and Vimovo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Colchicine (colchicine) and Vimovo (esomeprazole magnesium; naproxen). Common drug interactions include ankylosing spondylitis among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Colchicine and Vimovo. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Colchicine?

Colchicine has active ingredients of colchicine. It is often used in gout. eHealthMe is studying from 21,826 Colchicine users. Check the latest studies of Colchicine.

What is Vimovo?

Vimovo has active ingredients of esomeprazole magnesium; naproxen. It is often used in osteoarthritis. eHealthMe is studying from 9,608 Vimovo users. Check the latest studies of Vimovo.



On Jul, 06, 2026

32 people who take Colchicine and Vimovo together, and have interactions are studied.

Colchicine and Vimovo drug interactions.

What are the common drug interactions of Colchicine and Vimovo, by gender? *:

female:

  1. Ankylosing spondylitis (type of arthritis affecting the spine)
  2. Chronic kidney disease
  3. Renal failure (kidney dysfunction)
  4. Ankle fracture
  5. Arthralgia (joint pain)
  6. Cartilage injury
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Discomfort
  9. Drug ineffective
  10. Fatigue (feeling of tiredness)

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Acute myocardial infarction (acute heart attack)
  4. Ankylosing spondylitis (type of arthritis affecting the spine)
  5. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  6. Fungal infection
  7. Gastrointestinal inflammation (inflammation of stomach and intestine)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Muscle spasms (muscle contraction)
  10. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)

What are the common drug interactions of Colchicine and Vimovo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Ankylosing spondylitis (type of arthritis affecting the spine)
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Cerebral haemorrhage (bleeding within the brain)
  4. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  5. Arthralgia (joint pain)
  6. Cartilage injury
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Discomfort
  9. Drug ineffective
  10. Fatigue (feeling of tiredness)

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Abdominal pain
  5. Ankylosing spondylitis (type of arthritis affecting the spine)
  6. Fatigue (feeling of tiredness)
  7. Gastrointestinal inflammation (inflammation of stomach and intestine)
  8. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
  9. Iron deficiency
  10. Muscle spasms (muscle contraction)

50-59:

  1. Abdominal discomfort
  2. Asthenia (weakness)
  3. Fungal infection
  4. Headache (pain in head)
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Pain in extremity
  7. Sensory loss (senses loss)

60+:

  1. Chronic kidney disease
  2. Anaemia (lack of blood)
  3. Renal disorder (kidney disease)
  4. Renal injury (kidney injury)
  5. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  6. Renal failure (kidney dysfunction)
  7. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
  8. Ankle fracture
  9. Road traffic accident
  10. Acute myocardial infarction (acute heart attack)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 25.00%
  2. High Blood Pressure: 7 people, 21.88%
  3. Indigestion: 6 people, 18.75%
  4. Pain: 5 people, 15.62%
  5. Anaemia (lack of blood): 4 people, 12.50%
  6. Depression: 4 people, 12.50%
  7. Constipation: 3 people, 9.38%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 9.38%
  9. Hypersensitivity: 3 people, 9.38%
  10. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 9.38%

* Approximation only. Some reports may have incomplete information.

Do you take Colchicine and Vimovo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Colchicine and Vimovo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Colchicine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vimovo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Colchicine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vimovo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on colchicine and esomeprazole magnesium; naproxen (the active ingredients of Colchicine and Vimovo, respectively), and Colchicine and Vimovo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: